Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Natural volatiles and essential oils have health benefits and can enhance the effects of some medicines, but more research is needed to understand how they work and their possible side effects.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

WNT signaling is crucial for skin development and healing.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

A woman on immunosuppressants developed two rare scalp conditions, which improved with specific treatments.

Certain gene variations may increase the risk and severity of alopecia areata.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Accurate diagnosis of pseudolymphomatous folliculitis is crucial to avoid mistaking it for more serious conditions.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

A horse in Brazil with skin and gut issues was diagnosed with a severe disease and had to be euthanized.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.